BICRYOB: Endobiliary Percutaneous Cryobiopsy in Malignant Biliary Obstruction
Study Details
Study Description
Brief Summary
The rationale of the study is to explore the safety and efficacy of percutaneously performed endobiliary cryobiopsy in patiens with histologically unverified biliary stenosis.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
In patients with malignant biliary stenosis in whom endoscopic retrograde cholangiography (ERCP) is not feasible , percutaneous transhepatic drainage (PTD) is indicated. Biopsy is required for further management of the patient. In patients unsuitable for biopsy under CT or endoscopic guidance, samples can be collected endobiliary by PTD. The biopsy vie PTD can be sampled either at the initial drainage using disposable 5.2F forceps or delayed after 2 or more days using 7.5F endobiliary forceps. An alternative to this procedure is endobiliary sampling by cryobiopsy using 1.1mm, 1.7mm or 2.4mm catheters. To minimize bias, each patient will be sampled both by cryobiopsy and forceps biopsy. The order of cryobiopsy and forceps biopsy will be randomized.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Cryobiopsy In randomised patients in experimental arm was initially performed cryobiopsy (3 samples) and cosequently forceps biopsy (6 samples) with 5.2F or 7.5F forceps. Both sampling techniques were performed during one procedure of percutaneous transhepatic drainage under fluoroscopic control. |
Device: Cryobiopsy catheter
Comparison of endobiliary forceps biopsy and cryobiopsy of biliary stenosis during percutaneous transhepatic drainage.
|
Active Comparator: Forceps biopsy In randomised patients in control arm was initially performed forceps biopsy (6 samples) with 5.2F or 7.5F forceps and cosequently cryobiopsy (3 samples). Both sampling techniques were performed during one procedure of percutaneous transhepatic drainage under fluoroscopic control. |
Device: Cryobiopsy catheter
Comparison of endobiliary forceps biopsy and cryobiopsy of biliary stenosis during percutaneous transhepatic drainage.
|
Outcome Measures
Primary Outcome Measures
- Sensitivity of biopsy sampling to detect malignancy [up to month 12 or death of the patient]
Comparison of sensitivity of endobiliary cryobiopsy and forceps biopsy for detection of malignancy.
- Quality of samples collected by endobiliary cryobiopsy and forceps biopsy - weight [up to month 12 or death of the patient]
Comparison of weight (in milligrams) of samples collected by endobiliary cryopsy and forceps biopsy. Each sample will be weighed separately and one measurement value will be recorded for each sample.
- Quality of samples collected by endobiliary cryobiopsy and forceps biopsy - size [up to month 12 or death of the patient]
Comparison of the size weight (in millimeters) of samples collected by endobiliary cryopsy and forceps biopsy. Each sample will be weighed in two dimensions on slide.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
biliary stenosis of unknown etiology
-
unsuccessful or unfeasable ERCP
-
indicated percutaneous transhepatic drainage
Exclusion Criteria:
-
histologically verified biliary stenosis
-
INR ≥ 1,5
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Brno University Hospital | Brno | Czechia | 62500 |
Sponsors and Collaborators
- Brno University Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- FNBKRNM0003